Patent details

EP2451943 Title: METHODS AND COMPOSITIONS FOR USE IN CELLULAR THERAPIES

Basic Information

Publication number:
EP2451943
PCT Application Number:
PCT/IB/2010/001968
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP107521718
PCT Publication Number:
WO/2011/004264
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS AND COMPOSITIONS FOR USE IN CELLULAR THERAPIES
French Title of Invention:
PROCÉDÉS ET COMPOSITIONS POUR UTILISATION DANS DES THÉRAPIES CELLULAIRES
German Title of Invention:
VERFAHREN UND ZUSAMMENSETZUNGEN FÜR ZELLTHERAPIEN
SPC Number:

Dates

Filing date:
09/07/2010
Grant date:
23/11/2016
EP Publication Date:
23/11/2016
PCT Publication Date:
13/01/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/05/2012
EP B1 Publication Date:
23/11/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/07/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/03/2022
 
 

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, Doshomachi 4-chome, Chuo-ku, 541-0045, Osaka-Shi, Osaka, Japan (JP)

History of Owners

From:
09/07/2010
To:
04/03/2022

Name:
TiGenix S.A.U.
Address:
Parque Tecnológico de Madrid C/ Marconi, 1, 28760 Tres Cantos (Madrid), Spain (ES)

Agent

Name:
Office FREYLINGER S.A.
From:
01/02/2017
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
BUSCHER Dirk
Address:
Spain (ES)

2

Name:
LOMBARDO Eleuterio
Address:
Spain (ES)

Priority

Priority Number:
224275 P
Priority Date:
09/07/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 5/0783;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2022/05
Publication date:
01/04/2022
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20220000073A
Date Registered:
04/03/2022
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Baker & McKenzie
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, Doshomachi 4-chome, Chuo-ku, 541-0045, Osaka-Shi, Osaka, Japan (JP)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
17
Annual Fee Amount:
246 Euro
Expected Payer:
Last Annual Fee Payment Date:
19/06/2025
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
04/03/2022 Request For Change 18
01/02/2017 Power Of Attorney 1
08/03/2022 Outgoing Correspondence 1